ISIS Pharmaceuticals, Inc. – $ISIS – Confident Investor Rating: Poor

Company name ISIS Pharmaceuticals, Inc.
Stock ticker ISIS
Live stock price [stckqut]ISIS[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=isis

Isis Pharmaceuticals, Inc. develops therapeutic drugs inhibiting cell protein synthesis. The Company's principal activity is to develop and market RNA(RiboNucleicAcid)-based novel drugs to treat important diseases such as cardiovascular diseases, diabetes and asthma
Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in ISIS Pharmaceuticals, Inc. It is not possible to confidently invest in a company that is not currently profitable.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.